Agilent Technologies Inc.
Agilent Technologies Announces New Organizational Structure
Summary
Agilent Technologies, Inc. announced a reorganization of its operational structure into three new business groups: Life Sciences and Diagnostics Markets Group, Applied Markets Group, and Agilent CrossLab Group. This strategic shift aims to drive higher growth through a market-focused, customer-centric enterprise strategy. The new structure takes effect immediately, with fourth-quarter fiscal 2024 results reported under the existing structure and first-quarter 2025 results under the new structure.
Profitelligence Alerts
Get alerts for A
Be first to know when Agilent Technologies Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Agilent Technologies Inc.
Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.
Official SEC Documents
Advertisement